Perthera

Perthera is a healthcare technology company that provides personalized molecular cancer profiling through genomics and proteomics analysis. Through the company's PrecisOn process, Perthera provides oncologists with a comprehensive understanding of the molecular architecture of their patients' tumors. Multiple molecular analyses of each tumor are integrated into Perthera's Expert Oncologist system (ExpO), an expert learning database that sources the most current clinical knowledge and research and drug information available to facilitate actionable treatment recommendations. The platform supports clinical decision-making in oncology and precision medicine, enabling data-driven treatment selection. Founded in 2012 and headquartered in McLean, Virginia, Perthera has raised approximately $17.8 million in Series A funding from investors including Pilot Growth Equity and Invictus Growth.